Replimune Group, Inc. (REPL)

7.14 -0.08 (-1.11%) USD  |  NASDAQ  |  Mar 30, 12:35
More

Replimune Group Net Common Equity Issued (Purchased) (Annual)

Net Common Equity Issued (Purchased) (Annual) Chart

View Net Common Equity Issued (Purchased) (Annual) for REPL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Common Equity Issued (Purchased) (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Common Equity Issued (Purchased) (Annual) Range, Past 5 Years

View Net Common Equity Issued (Purchased) (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Common Equity Issued (Purchased) (Annual) Benchmarks

View Net Common Equity Issued (Purchased) (Annual) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. Upgrade
Phathom Pharmaceuticals, Inc. Upgrade
REGENXBIO, Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade